| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-A86708339 |
| PharmacoGx | BRD-A86708339 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CALU | CTRPv2 | pan-cancer | AAC | -0.33 | 2e-06 |
| mRNA | GPX8 | CTRPv2 | pan-cancer | AAC | -0.31 | 6e-07 |
| mRNA | RAB13 | CTRPv2 | pan-cancer | AAC | -0.3 | 4e-07 |
| mRNA | ANXA5 | CTRPv2 | pan-cancer | AAC | -0.29 | 4e-05 |
| mRNA | P4HA2 | CTRPv2 | pan-cancer | AAC | -0.28 | 5e-07 |
| mRNA | RAB11FIP5 | CTRPv2 | pan-cancer | AAC | -0.28 | 1e-06 |
| mRNA | VAMP3 | CTRPv2 | pan-cancer | AAC | -0.28 | 2e-06 |
| mRNA | FAM114A1 | CTRPv2 | pan-cancer | AAC | -0.27 | 4e-06 |
| mRNA | CTSB | CTRPv2 | pan-cancer | AAC | -0.27 | 3e-07 |
| mRNA | RP11-426L16.10 | CTRPv2 | pan-cancer | AAC | -0.27 | 7e-06 |
